Hemophagocytic syndrome in a patient with Fanconi anemia and VACTERL association
Main Article Content
Introduction: Hemophagocytic syndrome results from hyperactivity of histiocytes and lymphocytes, triggered by infections, mainly viral by cytomegalovirus, Epstein-Barr and herpes. Fanconi anemia (FA) is a rare genetic disease with heterogeneous symptoms common to other diseases such as VACTERL, a disease of unknown etiology in which there are several congenital malformations. The concomitance of Fanconi and VACTERL anemia occurs in 5 to 30% of FA patients. Report: A 14-month-old male infant was admitted to investigate fever, hepatosplenomegaly, and granulopenia. The patient was diagnosed with hemophagocytic syndrome due to hyperferritinemia, bone marrow hemophagocytosis, transaminase elevation, decreased fibrinogen, and cytomegalovirus (CMV) infection confirmed by serology and PCR. The test with mitomycin C (MMC) showed chromosomal fragility. The patient was diagnosed with a VACTERL/FA association for having a clinic and a test compatible with both FA and VACTERL. Conclusion: The VACTERL/FA association is seldom described, but is present in pediatric medical practice. This study presented the main clinical-laboratory aspects and reviewed the main aspects of the concurrence of this pathology.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY) that allows others to share and adapt the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Zen PRG, Moraes FN, Rosa FRM,Graziadio C, Paskulin GA. Características clínicas de pacientes com anemia de Fanconi. Rev Paul Pediatr. 2011;29(3):392-9. https://doi.org/10.1590/S0103-05822011000300014
Dufour C. How I manage patients with Fanconi anemia. Br J Haematol. 2017;178(1):32-47. https://doi.org/10.1111/bjh.14615
Schneider M, Chandler K, Tischkowitz M, Meyer S. Fanconianaemia: genetics, molecular biology, and cancer-implications for clinical management in children and adults. Clin Genet. 2014;88(1):13-24. https://doi.org/10.1111/cge.12517
Soulier J. Fanconi anemia. Hematol Am Soc Hematol Educ Program. 2011;2011:492-7. https://doi.org/10.1182/asheducation-2011.1.492
Deng W, Zhao M, Liu Y, Cao L, Yang M.Fanconi anemia in twins with neutropenia: a case report. Oncol Lett. 2018;16(4):5325-30. https://doi.org/10.3892/ol.2018.9304
Fiesco-Roa MO, Giri N, McReynoldsLJ, Best AF, Alter BP.Genotype-phenotype associations in Fanconi anemia: a literature review. Blood Rev. 2019;37:100589. https://doi.org/10.1016/j.blre.2019.100589
Alter BP, Rosenberg PS. VACTERL-H Association and Fanconi anemia. Mol Syndromol. 2013;4(1-2):87-93. https://doi.org/10.1159/000346035
Solomon BD, BakerLA, Bear KA, Cunningham BK, Giampietro PF, Hadigan C, et al. An Approach to the Identification of Anomalies and Etiologies in Neonates with Identifiedor Suspected VACTERL (Vertebral Defects, Anal Atresia, Tracheo-Esophageal Fistula with Esophageal Atresia, CardiacAnomalies, Renal Anomalies, andLimbAnomalies) Assoc J Pediatric. 2014;164(1):451-7. https://doi.org/10.1016/j.jpeds.2013.10.086
Liu Y, Ballman K, Li D, Khan S, Derr-Yellin E, Shou W, et al. Impaired function of Fanconi anemia type C-deficient macrophages. J Leukoc Biol. 2012;91(2):333-40. https://doi.org/10.1189/jlb.0811418
Guerrero-González GA, Martínez-Cabriales SA, Hernández-Juárez AA, Lugo-Trampe JJ, Espinoza-González NA, Gómez-Flores M, et al. Rothmund-Thomson Syndrome: A 13-Year Follow-Up. Case Rep Dermatol. 2014;6(2):176-9. https://doi.org/10.1159/000365625
Alter BP,Giri N. Thinking of VACTERL-H? Rule out Fanconi anemia according to PHENOS. Am J Med Genet. 2016;170(6):1520-4. https://doi.org/10.1002/ajmg.a.37637
Porteous ME, Cross I, Burn J. VACTERL with hydrocephalus: One end of the Fanconi anemia spectrum of anomalies? Am J Med Genet. 1992;43(6):1032-4. https://doi.org/10.1002/ajmg.1320430624
Giampietro PF, Adler-Brecher B, Verlander PC, Pavlakis SG, Davis JG, Auerbach AD. The need for more accurateandtimelydiagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry. Pediatrics. 1993;91(6):1116-20.
Faivre L, Portnoï MF, Pals G, Stoppa-Lyonnet D, Le Merrer M, Thauvin-Robinet C, et al. Should chromosome breakage studies be performed in patientswith VACTERL association? Am J Med Genet. 2005;137A(1):55-8. https://doi.org/10.1002/ajmg.a.30853
Botto LD, Khoury MJ, Mastroiacovo P, Castilla EE, Moore CA, Skjaerven R, et al. The spectrum of congenital anomalies of the VATER association: aninternational study. Am J Med Genet. 1997;71(1):8-15. https://doi.org/10.1002/(SICI)1096-8628(19970711)71:1<8::AID-AJMG2>3.0.CO;2-V